Literature DB >> 32893296

Prognosis of segmentectomy and lobectomy for radiologically aggressive small-sized lung cancer.

Atsushi Kamigaichi1, Yasuhiro Tsutani1, Takahiro Mimae1, Yoshihiro Miyata1, Hiroyuki Ito2, Haruhiko Nakayama2, Norihiko Ikeda3, Morihito Okada1.   

Abstract

OBJECTIVES: The purpose of this study was to determine the radiological characteristics of aggressive small-sized lung cancer and to compare the outcomes between segmentectomy and lobectomy in patients with these lung cancers.
METHODS: A series of 1046 patients with clinical stage IA1-IA2 lung cancer who underwent lobectomy or segmentectomy at 3 institutions was retrospectively evaluated to identify radiologically aggressive small-sized (solid tumour size ≤ 2 cm) lung cancers. Prognosis of segmentectomy was compared with that of lobectomy in 522 patients with radiologically aggressive small-sized lung cancer using propensity score matching.
RESULTS: Multivariable analysis showed that increasing consolidation-to-tumour ratio on preoperative high-resolution computed tomography (CT) (P = 0.037) and maximum standardized uptake on 18 fluoro-2-deoxyglucose positron emission tomography/CT (P = 0.029) was independently associated with worse recurrence-free survival. Based on analysis of the receiver operating characteristic curve, radiologically aggressive lung cancer was defined as a radiologically solid (consolidation-to-tumour ratio ≥ 0.8) or highly metabolic (maximum standardized uptake ≥ 2.5) tumour. Among patients with radiologically aggressive lung cancer, no significant statistical differences in 5-year recurrence-free (81% vs 90%; P = 0.33) and overall (88% vs 93%; P = 0.76) survival comparing lobectomy (n = 392) to segmentectomy (n = 130) were observed. Among 115 propensity-matched pairs, 5-year recurrence-free survival and overall survival were similar between patients who underwent lobectomy and those who underwent segmentectomy (83.3% and 88.3% vs 90.9% and 94.5%, respectively).
CONCLUSIONS: Difference in survival was not identified with segmentectomy and lobectomy in patients with radiologically aggressive small-sized lung cancer with high risk of recurrence.
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Lobectomy; Non-small-cell lung cancer; Segmentectomy

Mesh:

Year:  2020        PMID: 32893296     DOI: 10.1093/ejcts/ezaa231

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  4 in total

1.  Non-adjacent interlobar lymph node metastasis distant from small-sized peripheral non-small cell lung cancer.

Authors:  Tomohiro Maniwa; Toru Kimura; Masayuki Ohue; Yasushi Shintani; Jiro Okami
Journal:  Surg Today       Date:  2022-04-30       Impact factor: 2.549

Review 2.  A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 2: systematic review of evidence regarding resection extent in generally healthy patients.

Authors:  Frank C Detterbeck; Vincent J Mase; Andrew X Li; Ulas Kumbasar; Brett C Bade; Henry S Park; Roy H Decker; David C Madoff; Gavitt A Woodard; Whitney S Brandt; Justin D Blasberg
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

3.  Lobectomy versus segmentectomy: a propensity score-matched comparison of postoperative complications, pulmonary function and prognosis.

Authors:  Hiroaki Nomori; Ikuo Yamazaki; Youichi Machida; Ayumu Otsuki; Yue Cong; Hiroshi Sugimura; Yu Oyama
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-10-25

4.  A retrospective comparative cohort study on the efficacy and safety of bi-port robotic-assisted lobectomy and multi-port robotic-assisted lobectomy.

Authors:  Zenan Gu; Jia Huang; Yu Tian; Long Jiang; Qingquan Luo
Journal:  J Thorac Dis       Date:  2022-08       Impact factor: 3.005

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.